CD33 and malignant colon neoplasm: In addition, a population with Lin−/lowHLA-DR−CD11b+CD33+ phenotype has been demonstrated to have the features and properties of MDSCs in the blood from patients with glioblastoma, breast cancer, colon cancer, lung cancer or kidney cancer 15,26–29].